These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28422065)

  • 21. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
    Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
    J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The diagnostic value of detecting plasma 1, 3-beta-D-glucan for invasive fungal infections].
    Lü PH; Zhao BL; Shi Y; Wen YT
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jan; 30(1):31-4. PubMed ID: 17326970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
    Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
    Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.
    De Vlieger G; Lagrou K; Maertens J; Verbeken E; Meersseman W; Van Wijngaerden E
    J Clin Microbiol; 2011 Nov; 49(11):3783-7. PubMed ID: 21880959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
    Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
    Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.
    Cornu M; Sendid B; Mery A; François N; Mikulska M; Letscher-Bru V; De Carolis E; Damonti L; Titecat M; Bochud PY; Alanio A; Sanguinetti M; Viscoli C; Herbrecht R; Guerardel Y; Poulain D
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
    Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
    Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial.
    Flett L; Abdelatif R; Baz SA; Brady S; Corbacho B; Common K; Cowling A; Fairhurst C; Fitzmaurice E; Gandhi S; Hilton A; Hope W; Howard A; Laycock J; Lillie P; Mitchell G; Parker A; Peel M; Sheard L; Sneddon J; Taynton T; Tharmanathan P; Torgerson D; Wang HI; Allsup D; Barlow G
    Trials; 2024 Jun; 25(1):427. PubMed ID: 38943201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple serum antigenic assays for diagnosis of invasive fungal infections in non-neutropenic adult patients].
    Jin J; Sun TY; Hu YJ; Li YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):660-4. PubMed ID: 21092632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of albumin on (1, 3)-β-D-glucan for diagnosis of invasive fungal infections].
    Han S; Su X; Zhao R; Fang K
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):672-6. PubMed ID: 26255017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
    Lamoth F; Cruciani M; Mengoli C; Castagnola E; Lortholary O; Richardson M; Marchetti O;
    Clin Infect Dis; 2012 Mar; 54(5):633-43. PubMed ID: 22198786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
    Koo S; Baden LR; Marty FM
    Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
    Jaijakul S; Vazquez JA; Swanson RN; Ostrosky-Zeichner L
    Clin Infect Dis; 2012 Aug; 55(4):521-6. PubMed ID: 22573851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoalveolar Lavage Fluid (1,3)β-D-Glucan for the Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study.
    Mutschlechner W; Risslegger B; Willinger B; Hoenigl M; Bucher B; Eschertzhuber S; Lass-Flörl C
    Transplantation; 2015 Sep; 99(9):e140-4. PubMed ID: 25710608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.
    Lo Cascio G; Koncan R; Stringari G; Russo A; Azzini A; Ugolini A; Ligozzi M; Polati E; Cornaglia G; Concia E; Schweiger V
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):357-65. PubMed ID: 25217227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Odabasi Z; Mattiuzzi G; Estey E; Kantarjian H; Saeki F; Ridge RJ; Ketchum PA; Finkelman MA; Rex JH; Ostrosky-Zeichner L
    Clin Infect Dis; 2004 Jul; 39(2):199-205. PubMed ID: 15307029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.